3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urologic Diseases
2
Urinary Bladder Neoplasms
2
Urinary Bladder Diseases
2
Carcinoma, Transitional Cell
2
Interventions
Mitomycin
3
vofatamab
2
pembrolizumab
2
B701 protein, Human herpesvirus 6
2
valrubicin
1
trifluridine tipiracil drug combination
1
palbociclib
1
enfortumab vedotin
1
atezolizumab
1
Water
1
Sunitinib
1
Standard of Care
1
Radiation Dose Hypofractionation
1
Gemcitabine
1
Gels
1
Fluorouracil
1
Docetaxel
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Urologic Diseases
×
B701 protein, Human herpesvirus 6
×
Clear all
NCT03123055
2020-03-18
FIERCE-22
Rainier Therapeutics
Phase 1/2
Terminated
28 enrolled
8 charts
NCT02401542
2020-03-09
FIERCE-21
Rainier Therapeutics
Phase 1/2
Terminated
71 enrolled
9 charts